171 related articles for article (PubMed ID: 35146349)
1. Complicated carbapenem-resistant infections: a treatment pathway analysis in Italian sites.
Durante-Mangoni E; Bertolino L; Mastroianni C; Viale P; Bassetti M; Citton R; Gómez-Ulloa D; Roset M; McCann E
Infez Med; 2021; 29(3):434-449. PubMed ID: 35146349
[TBL] [Abstract][Full Text] [Related]
2. Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in Spain.
Ferrer R; Fariñas MC; Maseda E; Salavert M; Bou G; Díaz-Regañón J; López D; Lozano V; Gómez-Ulloa D; Fenoll R; Lara N; McCann E
Rev Esp Quimioter; 2021 Dec; 34(6):639-650. PubMed ID: 34806858
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of the novel siderophore cephalosporin, cefiderocol, in Gram-negative pathogens in Europe by site of infection.
Candel FJ; Santerre Henriksen A; Longshaw C; Yamano Y; Oliver A
Clin Microbiol Infect; 2022 Mar; 28(3):447.e1-447.e6. PubMed ID: 34298176
[TBL] [Abstract][Full Text] [Related]
4. Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination.
Mansour H; Ouweini AEL; Chahine EB; Karaoui LR
Am J Health Syst Pharm; 2021 Mar; 78(8):674-683. PubMed ID: 33580649
[TBL] [Abstract][Full Text] [Related]
5. Risk of relapse and readmission among hospitalized adults with carbapenem non-susceptible gram-negative infections.
Dillon R; Burton T; Anderson AJ; Seare J; Puzniak L
Curr Med Res Opin; 2023 Jun; 39(6):881-888. PubMed ID: 37178145
[TBL] [Abstract][Full Text] [Related]
6. Investigation and analysis of carbapenem-resistant gram-negative bacterial infection rates across hospitals in Shandong Province in China.
Liu K; Xu H; Sun J; Liu Y; Li W
Front Public Health; 2022; 10():1014995. PubMed ID: 36420011
[TBL] [Abstract][Full Text] [Related]
7. Determining the burden of infectious diseases caused by carbapenem-resistant gram-negative bacteria in Spain.
Cantón R; Huarte R; Morata L; Trillo-Mata JL; Muñoz R; González J; Tort M; Badia X
Enferm Infecc Microbiol Clin (Engl Ed); 2021 Apr; 39(4):179-183. PubMed ID: 32576392
[TBL] [Abstract][Full Text] [Related]
8. Bloodstream infections in children caused by carbapenem-resistant versus carbapenem-susceptible gram-negative microorganisms: Risk factors and outcome.
Ozsurekci Y; Aykac K; Cengiz AB; Basaranoglu ST; Sancak B; Karahan S; Kara A; Ceyhan M
Diagn Microbiol Infect Dis; 2017 Apr; 87(4):359-364. PubMed ID: 28089138
[TBL] [Abstract][Full Text] [Related]
9. Use of hospital resources in ICU inpatients with infections caused by carbapenem-resistant Gram-negative bacteria: A real clinical practice-based study in Spain.
Ferrer R; Garnacho-Montero J; Rascado P; Contreras S; Cantón-Bulnes L; Barral P; Del Cerro I; Badia X
Enferm Infecc Microbiol Clin (Engl Ed); 2023 Mar; 41(3):162-168. PubMed ID: 36610832
[TBL] [Abstract][Full Text] [Related]
10. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
Pang F; Jia XQ; Zhao QG; Zhang Y
Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
[TBL] [Abstract][Full Text] [Related]
11. The prospective evaluation of risk factors and clinical influence of carbapenem resistance in children with gram-negative bacteria infection.
Sahbudak Bal Z; Bekmezci N; Soylu M; Sen S; Avcu G; Aydemir S; Vardar F
Am J Infect Control; 2018 Feb; 46(2):147-153. PubMed ID: 28982610
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic consumption versus the prevalence of carbapenem-resistant Gram-negative bacteria at a tertiary hospital in China from 2011 to 2017.
Zhang D; Hu S; Sun J; Zhang L; Dong H; Feng W; Lei J; Dong Y
J Infect Public Health; 2019; 12(2):195-199. PubMed ID: 30385238
[TBL] [Abstract][Full Text] [Related]
13. Molecular Surveillance of Carbapenem-Resistant Gram-Negative Bacteria in Liver Transplant Candidates.
Schultze TG; Ferstl PG; Villinger D; Hogardt M; Bechstein WO; Göttig S; Wichelhaus TA; Zeuzem S; Trebicka J; Waidmann O; Welker MW; Kempf VAJ
Front Microbiol; 2021; 12():791574. PubMed ID: 34880850
[No Abstract] [Full Text] [Related]
14. Carbapenem-resistant Gram-negative bacteria - analysis of the data obtained through a mandatory reporting system in the Rhine-Main region, Germany, 2012-2015.
Heudorf U; Büttner B; Hauri AM; Heinmüller P; Hunfeld KP; Kaase M; Kleinkauf N; Albert-Braun S; Tessmann R; Kempf VA
GMS Hyg Infect Control; 2016; 11():Doc10. PubMed ID: 27274441
[TBL] [Abstract][Full Text] [Related]
15. Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections.
Lodise TP; Bonine NG; Ye JM; Folse HJ; Gillard P
BMC Infect Dis; 2019 Aug; 19(1):718. PubMed ID: 31412809
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.
Liu J; Zhang L; Pan J; Huang M; Li Y; Zhang H; Wang R; Zhao M; Li B; Liu L; Gong Y; Bian J; Li X; Tang Y; Lei M; Chen D
J Infect Dis; 2020 Mar; 221(Suppl 2):S156-S163. PubMed ID: 32176797
[TBL] [Abstract][Full Text] [Related]
17. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic evaluation of cefiderocol for the treatment of multidrug resistant Gram-negative infections.
Drwiega EN; Griffith NC; Danziger LH
Expert Opin Drug Metab Toxicol; 2022 Apr; 18(4):245-259. PubMed ID: 35594628
[TBL] [Abstract][Full Text] [Related]
19. Impact of bloodstream infections caused by carbapenem-resistant Gram-negative pathogens on ICU costs, mortality and length of stay.
Kousouli E; Zarkotou O; Polimeri K; Themeli-Digalaki K; Pournaras S
Infect Prev Pract; 2019 Jun; 1(2):100020. PubMed ID: 34368681
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal Carriage of Vancomycin-Resistant Enterococci and Carbapenem-Resistant Gram-Negative Bacteria in an Endemic Setting: Prevalence, Risk Factors, and Outcomes.
Vasilakopoulou A; Karakosta P; Vourli S; Tarpatzi A; Varda P; Kostoula M; Antoniadou A; Pournaras S
Front Public Health; 2020; 8():55. PubMed ID: 32257988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
